Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Abstract Background Doxorubicin remains one of the most common causes of cardiotoxicity in patients with lymphoma, leading to significant morbidity and mortality. Early decline in left ventricular (LV) ejection fraction predicts chemotherapy-induced cardiotoxicity and mortality, but limited data exi...
Main Authors: | Maria Isabel Camara Planek, Ahmad Manshad, Kyaw Hein, Mohamad Hemu, Fatima Ballout, Rajiv Varandani, Parameswaran Venugopal, Tochukwu Okwuosa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Cardio-Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40959-020-00066-8 |
Similar Items
-
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01) -
Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats
by: Yan-Yan Zhang, et al.
Published: (2017-09-01) -
Advances of MicroRNA in the diagnosis and mechanism of doxorubicin-induced cardiotoxicity
by: Yi-Xin Su, et al.
Published: (2021-01-01) -
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01) -
Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin
by: Wei Shi, et al.
Published: (2018-06-01)